¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀå
Artificial Ventilation and Anesthesia Masks
»óǰÄÚµå : 1785744
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 282 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀº 2030³â±îÁö 29¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 24¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 3.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 29¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÏȸ¿ë ¸¶½ºÅ©´Â CAGR 4.5%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 16¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Àç»ç¿ë °¡´É ¸¶½ºÅ© ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 2.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 4,230¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR6.8%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀº 2024³â¿¡ 6¾ï 4,230¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â°£ CAGR 6.8%·Î 2030³â±îÁö 5¾ï 8,910¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 1.4%¿Í 2.8%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.1%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±â¼ú Çõ½ÅÀ» ÅëÇÑ ÀΰøÈ£Èí ¹× ¸¶Ãë ¸¶½ºÅ© °­È­¶õ?

ÀΰøÈ£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀº º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀΠȣÈí °ü¸®ÀÇ Çʿ伺À¸·Î ÀÎÇØ ±â¼ú Çõ½ÅÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÃֽЏ¶½ºÅ©´Â ´õ ³ªÀº ¹ÐÆó¼º, Æí¾ÈÇÔ, ³»±¸¼ºÀ» Á¦°øÇÏ´Â °í±Þ Àç·á·Î ¼³°èµÇ¾ú½À´Ï´Ù. Ç×±Õ ÄÚÆÃ ¹× ÀÏȸ¿ë ¿É¼ÇÀº ƯÈ÷ °íÀ§Çè ȯ°æ¿¡¼­ °¨¿° Á¦¾î ¹®Á¦¿¡ ´ëÇÑ ¼Ö·ç¼ÇÀ¸·Î µîÀåÇß½À´Ï´Ù. ¶ÇÇÑ Á¶Á¤ °¡´ÉÇÑ ¾Ð·Â ¼³Á¤°ú ÅëÇÕ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» °®Ãá ¸¶½ºÅ©ÀÇ °³¹ß·Î Á¤È®Çϰí È¿°úÀûÀΠȯ±â¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº È£Èí Ä¡·áÀÇ ¼öÁØÀ» Çâ»ó½ÃŰ´Â µ¥ ÀÖ¾î ±â¼úÀÌ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ½À» ºÐ¸íÈ÷ º¸¿©ÁÝ´Ï´Ù.

ȯ±â ¹× ¸¶Ãë ¸¶½ºÅ©ÀÇ ¹Ì·¡¸¦ °áÁ¤Áþ´Â Æ®·»µå´Â ¹«¾ùÀϱî?

¸î °¡Áö Æ®·»µå°¡ Àΰø È£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. Äڷγª19 »çÅ´ ȣÈí±â °ü¸®ÀÇ Á߿伺À» ºÎ°¢½ÃÄ×°í, ¸¶½ºÅ© »ý»ê°ú ±â¼ú Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ¸¦ Áõ°¡½ÃÄ×½À´Ï´Ù. ¸¸¼º È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅÃÄ¡·á ¹× ÈÞ´ë¿ë ÀΰøÈ£Èí±â ½Ã½ºÅÛÀÇ µîÀåÀ¸·Î ½ÃÀåÀº º´¿ø ¿Ü¿¡µµ Àå±âÀûÀÎ Ä¡·á°¡ ÇÊ¿äÇÑ È¯Àڵ鿡°Ôµµ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¼Ó°¡´É¼ºµµ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ°í ÀÖÀ¸¸ç, Á¦Á¶¾÷üµéÀº ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̱â À§ÇØ »ýºÐÇØ¼º ¼ÒÀç¿Í ÀçȰ¿ë °¡´ÉÇÑ ¼ÒÀ縦 ¸ð»öÇϰí ÀÖ½À´Ï´Ù.

ȯ±â ¹× ¸¶Ãë ¸¶½ºÅ©°¡ Çö´ë ÀÇ·á¿¡ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ȯ±â ¹× ¸¶Ãë¿ë ¸¶½ºÅ©´Â ÁßÁõ È£Èí±â Áúȯ ¹× ¸¸¼º È£Èí±â Áúȯ °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¼ö¼ú ÇöÀå¿¡¼­ ÀÌ ¸¶½ºÅ©´Â ¸¶Ãë °¡½ºÀÇ ¾ÈÀüÇÑ °ø±ÞÀ» º¸ÀåÇϰí ħ½ÀÀû ½Ã¼ú¿¡ µû¸¥ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. È£Èí±â ÁúȯÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô ¸¶½ºÅ©´Â ÀϰüµÈ ȯ±â Áö¿øÀ» Á¦°øÇÏ°í »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÎü°øÇÐ ¹× Àç·á°úÇÐÀÇ ¹ßÀüÀ¸·Î ƯÈ÷ Àå±â »ç¿ëÀÚÀÇ ÄÄÇöóÀ̾𽺰¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ °¨¿° ÅëÁ¦¸¦ ¿ì¼±½ÃÇÏ´Â °¡¿îµ¥, ÀÏȸ¿ë ¸¶½ºÅ©¿Í ÀÏȸ¿ë ¸¶½ºÅ©ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, ±â´É¼ºÀº ±×´ë·Î À¯ÁöÇϸ鼭 ¾ÈÀü¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº °Ç°­ °ü¸®¿¡¼­ ¸¶½ºÅ©ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÀΰøÈ£Èí ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ÀΰøÈ£Èí±â ¹× ¸¶Ãë ¸¶½ºÅ© ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ¼ö¿ä Áõ°¡, ±â¼ú Çõ½Å, ȯÀÚÃþÀÇ º¯È­ µî ¿©·¯ °¡Áö ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. COPD, õ½Ä µî È£Èí±â Áúȯ Áõ°¡·Î ÀÎÇØ ÷´Ü ȯ±â ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °æ·® ¼ÒÀç¿Í ¾Á¸µ ¸ÞÄ¿´ÏÁòÀÇ °³¼± µî ¸¶½ºÅ© µðÀÚÀÎÀÇ Çõ½ÅÀº ȯÀÚÀÇ Æí¾ÈÇÔ°ú ÁؼöÀ²À» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÇコÄÉ¾î ¼­ºñ½º È®´ë¿Í È£Èí±â Ä¡·á¿¡ ´ëÇÑ Á¤ºÎ º¸Á¶±Ý Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÃËÁø¿äÀÎÀº ¼¼°è ÇコÄÉ¾î °úÁ¦¿¡ ´ëÀÀÇÏ´Â µ¥ ÀÖ¾î ȯ±â ¹× ¸¶Ãë¿ë ¸¶½ºÅ©ÀÇ Àü·«Àû Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

ºÎ¹®

À¯Çü(ÀÏȸ¿ë ¸¶½ºÅ©, ÀçÀÌ¿ë °¡´É ¸¶½ºÅ©), ¿ëµµ(¼ö¼ú½Ç ¿ëµµ, ICU ¿ëµµ, ÀçÅÃÄ¡·á ¿ëµµ, ±¸¸í ±¸±Þ½Ç ¿ëµµ, ASC ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Artificial Ventilation and Anesthesia Masks Market to Reach US$2.9 Billion by 2030

The global market for Artificial Ventilation and Anesthesia Masks estimated at US$2.4 Billion in the year 2024, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Disposable Masks, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Reusable Masks segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$642.3 Million While China is Forecast to Grow at 6.8% CAGR

The Artificial Ventilation and Anesthesia Masks market in the U.S. is estimated at US$642.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$589.1 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Artificial Ventilation and Anesthesia Masks Market - Key Trends & Drivers Summarized

How Are Innovations Enhancing Artificial Ventilation and Anesthesia Masks?

The artificial ventilation and anesthesia masks market has witnessed a surge in innovation, driven by the need for safer, more efficient respiratory care. Modern masks are designed with advanced materials that provide better sealing, comfort, and durability. Antimicrobial coatings and disposable options have emerged as solutions to infection control challenges, especially in high-risk environments. Additionally, the development of masks with adjustable pressure settings and integrated monitoring systems ensures precise and effective ventilation. These advancements underscore the critical role of technology in elevating respiratory care standards.

What Trends Are Defining the Future of Ventilation and Anesthesia Masks?

Several trends are shaping the market for artificial ventilation and anesthesia masks. The COVID-19 pandemic highlighted the importance of respiratory care, leading to increased investments in mask production and innovation. The growing prevalence of chronic respiratory diseases, coupled with an aging population, has created a sustained demand for these devices. Moreover, the rise of home healthcare and portable ventilation systems has expanded the market beyond hospitals, catering to patients requiring long-term care. Sustainability is also becoming a key focus, with manufacturers exploring biodegradable and recyclable materials to reduce environmental impact.

Why Are Ventilation and Anesthesia Masks Vital in Modern Healthcare?

Ventilation and anesthesia masks are indispensable in managing critical and chronic respiratory conditions. In surgical settings, these masks ensure the safe delivery of anesthetic gases, minimizing risks associated with invasive procedures. For patients with respiratory diseases, masks provide consistent ventilation support, enhancing quality of life. Advances in ergonomics and material science have improved patient compliance, particularly for long-term users. As healthcare systems prioritize infection control, disposable and single-use masks are gaining popularity, ensuring safety without compromising functionality. These factors highlight the essential role of masks in healthcare.

What Drives the Growth in the Artificial Ventilation and Anesthesia Masks Market?

The growth in the artificial ventilation and anesthesia masks market is driven by several factors, including rising healthcare needs, technological innovations, and shifting patient demographics. The increasing incidence of respiratory disorders, such as COPD and asthma, has created a significant demand for advanced ventilation solutions. Innovations in mask design, including lightweight materials and improved sealing mechanisms, are enhancing patient comfort and compliance. The expansion of healthcare services in emerging markets and increased government funding for respiratory care are also bolstering market growth. These drivers emphasize the strategic importance of ventilation and anesthesia masks in addressing global healthcare challenges.

SCOPE OF STUDY:

The report analyzes the Artificial Ventilation and Anesthesia Masks market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Disposable Masks, Reusable Masks); Application (Operating Rooms Application, ICUs Application, Homecare Application, Emergency Rooms Application, ASCs Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â